CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 2.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,154,000 | -46.6% | 285,133 | -57.3% | 0.07% | -53.1% |
| Q2 2021 | $7,773,000 | +214.2% | 667,224 | +229.0% | 0.14% | +163.6% |
| Q1 2021 | $2,474,000 | -61.2% | 202,806 | -60.2% | 0.06% | -67.5% |
| Q4 2020 | $6,381,000 | -53.6% | 510,088 | -44.2% | 0.17% | -62.5% |
| Q3 2020 | $13,766,000 | -14.8% | 914,662 | +38.7% | 0.45% | -29.5% |
| Q2 2020 | $16,162,000 | – | 659,395 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |